These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 18202712
1. Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. Arias L, Armadá F, Donate J, García-Arumí J, Giralt J, Pazos B, Piñero A, Martínez F, Mondéjar JJ, Ortega I, Zlateva G, Buggage R. Eye (Lond); 2009 Feb; 23(2):326-33. PubMed ID: 18202712 [Abstract] [Full Text] [Related]
2. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Mruthyunjaya P, Stinnett SS, Toth CA. Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328 [Abstract] [Full Text] [Related]
7. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation. Moutray T, Alarbi M, Mahon G, Stevenson M, Chakravarthy U. Br J Ophthalmol; 2008 Mar; 92(3):361-4. PubMed ID: 18303157 [Abstract] [Full Text] [Related]
8. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration. Shah AR, Del Priore LV. Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101 [Abstract] [Full Text] [Related]
9. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Rotenstreich Y, Fishman GA, Anderson RJ. Ophthalmology; 2003 Jun; 110(6):1151-8. PubMed ID: 12799240 [Abstract] [Full Text] [Related]
13. Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration. Oliver-Fernandez A, Bakal J, Segal S, Shah GK, Dugar A, Sharma S. Can J Ophthalmol; 2005 Jun; 40(3):313-9. PubMed ID: 15947801 [Abstract] [Full Text] [Related]
14. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Slakter JS, Stur M. Surv Ophthalmol; 2005 Jun; 50(3):263-73. PubMed ID: 15850815 [Abstract] [Full Text] [Related]
15. One-year outcomes of less frequent bevacizumab in age-related macular degeneration. Sonmez K, Sonmez PA, Ozkan SS, Atmaca LS. Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363 [Abstract] [Full Text] [Related]
16. Transpupillary thermotherapy for choroidal neovascular membrane in age related macular degeneration. Agarwal M, Shanmugam MP, Gopal L, Shetty N, Bhende M, Gopal L, Sharma T, Thakur S, Raman R, Nizamuddin SH, Moorthy KR. Indian J Ophthalmol; 2004 Mar; 52(1):45-9. PubMed ID: 15132379 [Abstract] [Full Text] [Related]
19. [Natural course and prognosis of visual acuity in patients of age-related macular degeneration with occult choroidal neovascularization]. Zhang CF, Li ZQ, Du H, Han BL. Zhonghua Yan Ke Za Zhi; 2003 Jul; 39(7):415-8. PubMed ID: 12921672 [Abstract] [Full Text] [Related]
20. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Avila MP, Farah ME, Santos A, Kapran Z, Duprat JP, Woodward BW, Nau J. Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]